Location History:
- Allschwil, CH (1994)
- Basel, CH (2006)
- Bottmingen, CH (1995 - 2013)
Company Filing History:
6 out of 414 
6 out of 68 
5 out of 1,603 
Years Active: 1994-2013
Title: Martin Eberle: Innovator in Pharmaceutical Chemistry
Introduction
Martin Eberle, based in Bottmingen, Switzerland, is a prominent inventor with a remarkable portfolio of 21 patents. His innovative contributions primarily focus on pharmaceutical compounds aimed at treating neoplastic and autoimmune diseases. Eberle's work exemplifies the intersection of chemistry and medicine, providing crucial advancements in therapeutic options.
Latest Patents
Among Martin Eberle's latest patents are two significant inventions:
1. **Aroylfuranes and Aroylthiophenes** - This invention involves novel substituted 2-(phenyl-, pyridyl- or pyrimidyl-carbonyl)-furanes and -thiophenes, as well as phenoxy/phenylthio-acetophenones and related heterocyclic compounds. The patent details processes for preparing these compounds, pharmaceutical compositions that incorporate them, and their application in the treatment of neoplastic and autoimmune diseases.
2. **Phenylaminopyridines** - This patent focuses on new substituted 3-phenylamino-5-(3-aminophenyl)pyridines and corresponding pyrazines, which have important therapeutic implications. Similar to his previous work, it includes preparation methods, pharmaceutical compositions, and their use in treating neoplastic diseases and autoimmune disorders.
Career Highlights
Martin has built an impressive career in the pharmaceutical industry, contributing to various innovative projects. He has worked with renowned companies, including Syngenta Crop Protection, Inc. and Basilea Pharmaceutica AG. His role in these organizations highlights his significant impact within the field of pharmaceutical research and his commitment to developing new therapeutics.
Collaborations
Throughout his career, Martin Eberle has collaborated with notable colleagues such as Felix Bachmann and Fritz Schaub. These partnerships have contributed to the advancement of research and development efforts, reinforcing the importance of teamwork in the innovation process.
Conclusion
Martin Eberle stands out as a visionary inventor in pharmaceutical chemistry. With his extensive patent portfolio and collaborations in the industry, he continues to pave the way for innovative treatments for complex diseases. Eberle's contributions not only demonstrate his scientific expertise but also reflect a commitment to improving patient outcomes through advancing medical science.